CAS: 2245072-21-1
LIT-001
CAS:2245072-21-1
LIT-001 improves social interaction in a mouse model of autism.It is the first nonpeptide oxytocin …
Fórmula:
C30H34F3N7O4S
Pureza:
96.88% - 98.25%
Forma y color:
Solid
Peso molecular:
645.7
Ref: TM-T11857
| 1mg | 71,00 € | ||
| 5mg | 154,00 € | ||
| 10mg | 276,00 € | ||
| 25mg | 437,00 € | ||
| 50mg | 645,00 € | ||
| 100mg | 917,00 € | ||
| 500mg | 1.789,00 € | ||
| 1mL*10mM (DMSO) | 214,00 € |
Entrega estimada en Estados Unidos, el Jueves 5 de Diciembre de 2024
![(S)-2-(Dimethylcarbamothioyl)-N-(2-methyl-4-(1-methyl-1,4,5,10-tetrahydrobenzo[b]pyrazolo[3,4-e]...](https://static.cymitquimica.com/products/IN/thumb/DA01V2NM.jpg)
(S)-2-(Dimethylcarbamothioyl)-N-(2-methyl-4-(1-methyl-1,4,5,10-tetrahydrobenzo[b]pyrazolo[3,4-e][1,4]diazepine-5-carbonyl)benzyl)pyrrolidine-1-carboxamide, Trifluoroacetate
CAS:2245072-21-1
Fórmula:
C30H33F3N7O4S
Pureza:
98%
Peso molecular:
644.6877
Ref: IN-DA01V2NM
| 5mg | 99,00 € | ||
| 10mg | 136,00 € | ||
| 25mg | 192,00 € | ||
| 50mg | 323,00 € | ||
| 100mg | 516,00 € |
Entrega estimada en Estados Unidos, el Jueves 5 de Diciembre de 2024
LIT-001
CAS:2245072-21-1
LIT-001 is a new drug in development for the treatment of pain. LIT-001 is a …
Fórmula:
C30H34F3N7O4S
Pureza:
Min. 95%
Peso molecular:
645.7 g/mol
Ref: 3D-VPD07221
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 16 de Enero de 2025
